We are live on ! Find out more
DRTSW icon

Alpha Tau Medical Warrant

28 hedge funds and large institutions have $1.54M invested in Alpha Tau Medical Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $1.3M → $1.54M (+$241K)

0.95% more ownership

Funds ownership: 4.76%5.71% (+0.95%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

13% less funds holding

Funds holding: 3228 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
28
Holders Change
-4
Holders Change %
-12.5%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
3
Closed
6
Calls
$524K
Puts
Net Calls
+$524K
Net Calls Change
+$128K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
26
Parallel Advisors
California
$2.21K +$1.71K +5,600 New
Morgan Stanley
27
Morgan Stanley
New York
$1.01K
TRCT
28
Tower Research Capital (TRC)
New York
$141
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
-$29K -100,000 Closed
Two Sigma Investments
30
Two Sigma Investments
New York
-$8.76K -31,286 Closed
WAM
31
Warberg Asset Management
Illinois
-$6.64K -22,900 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
-$5.65K -17,282 Closed
HF
33
HRT Financial
New York
-$3K -11,010 Closed
TJHA
34
Thomas J. Herzfeld Advisors
Florida
-$689 -2,109 Closed

DRTSW Hedge Fund Activity: Q2 2023 in Review

28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical Warrant (DRTSW) for Q2 2023, worth a combined $1.54M — up 19% from $1.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of DRTSW and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Corbin Capital Partners, adding an estimated $217K. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $29K sold.

  • 28 institutional investors held Alpha Tau Medical Warrant (DRTSW) as of Q2 2023, down from 32 in Q1 2023.
  • Funds reported $1.54M of Alpha Tau Medical Warrant stock for Q2 2023, up 19% quarter-over-quarter.
  • 2 funds opened new Alpha Tau Medical Warrant positions in Q2 2023 and 6 closed out, a net change of -4 holders.
  • The largest Alpha Tau Medical Warrant buyer in Q2 2023 was Corbin Capital Partners, an estimated $217K added.
  • The largest Alpha Tau Medical Warrant seller in Q2 2023 was Balyasny Asset Management, an estimated $29K sold.

Based on aggregated 13F filings for Q2 2023.